A carregar...
PPARγ Inhibitors as Novel Tubulin-Targeting Agents
The microtubule-targeting agents (MTAs) are a very successful class of cancer drugs with therapeutic benefits in both hematopoietic and solid tumors. However, resistance to these drugs is a significant problem. Current MTAs bind to microtubules, and/or to their constituent tubulin heterodimers, and...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi Publishing Corporation
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2396401/ https://ncbi.nlm.nih.gov/pubmed/18509498 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2008/785405 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|